5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2)

NCT00761735 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

BIOLOGICAL: Peginterferon alfa-2b
DRUG: Ribavirin

Sponsor

Merck Sharp & Dohme LLC